AORT – artivion, inc. (US:NASDAQ)
Stock Stats
News
Artivion (AORT) had its "buy" rating reaffirmed by Needham & Company LLC.
How The Investment Story Is Shifting For Artivion (AORT) After Recent Analyst And FDA Updates [Yahoo! Finance]
1 Stock Under $50 to Own for Decades and 2 We Avoid [Yahoo! Finance]
Artivion (AORT) was upgraded by LADENBURG THALM/SH SH from "neutral" to "buy". They now have a $42.00 price target on the stock.
Artivion Secures FDA Approval for NEXUS Aortic Arch System [Yahoo! Finance]
Form ARS ARTIVION, INC. For: Dec 31
Form DEFA14A ARTIVION, INC.
Form DEF 14A ARTIVION, INC. For: May 12
Form SCHEDULE 13G/A ARTIVION, INC. Filed by: VANGUARD GROUP INC
Form 4 ARTIVION, INC. For: Mar 02 Filed by: Horton Amy
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.